Old Web
English
Sign In
Acemap
>
authorDetail
>
Timothy Devos
Timothy Devos
Universitaire Ziekenhuizen Leuven
Anemia
Myelofibrosis
Constitutional symptoms
Medicine
Physical therapy
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Association of transfusion independence with improved overall survival in myelofibrosis patients receiving momelotinib.
2021
Journal of Clinical Oncology
Ruben A. Mesa
Stephen T. Oh
Aaron T. Gerds
Vikas Gupta
John Catalano
Francisco Cervantes
Timothy Devos
Marek Hus
Jean-Jacques Kiladjian
Ewa Lech-Marańda
Donal McLornan
Jeanne Palmer
Uwe Platzbecker
Jacek Treliński
Kazuya Shimoda
Rafe Donahue
Bryan Strouse
Mark Kowalski
Srdan Verstovsek
Show All
Source
Cite
Save
Citations (1)
Phase III randomized, double-blind, active-controlled study of momelotinib versus ruxolitinib in patients with myelofibrosis.
2015
Journal of Clinical Oncology
Elliott F. Winton
Timothy Devos
Stephen T. Oh
Uwe Platzbecker
Martha Wadleigh
Susie Jun
Peter D. Lee
Wei Deng
Vikas Gupta
Show All
Source
Cite
Save
Citations (1)
1